1-4 of 4
Robert J Markelewicz, Jr., MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Selective HDAC6 Inhibitor ACY-241, an Oral Tablet, Combined with Pomalidomide and Dexamethasone: Safety and Efficacy of Escalation and Expansion Cohorts in Patients with Relapsed or Relapsed-and-Refractory Multiple Myeloma (ACE-MM-200 Study)

Ruben Niesvizky, MD, Paul G. Richardson, MD, Andrew J. Yee, MD, Ajay K Nooka, Marc S Raab, Kenneth H. Shain, MD PhD, Nashat Y. Gabrail, MD, Jeffrey Matous, MD, Amit B. Agarwal, James Hoffman, MD, Sumit Madan, MD, John M. Pagel, MD PhD, Jesus San Miguel, MD PhD, Philippe Moreau, Maria-Victoria Mateos, MD PhD, Thierry Facon, David Tamang, PhD, Simon S Jones, PhD, Robert J Markelewicz, Jr., MD, Catherine Wheeler, MD, Nikolaus S. Trede, MD PhD, Noopur Raje, MD, Evangelos Terpos, William I. Bensinger, MD
Journal: Blood
Blood (2016) 128 (22): 3307.
https://doi.org/10.1182/blood.V128.22.3307.3307
Published: 2016
Journal Articles

Ricolinostat (ACY-1215), the First Selective HDAC6 Inhibitor, Combines Safely with Pomalidomide and Dexamethasone and Shows Promosing Early Results in Relapsed-and-Refractory Myeloma (ACE-MM-102 Study)

Noopur S. Raje, MD, William Bensinger, MD, Craig E. Cole, MD, Sagar Lonial, MD, Sundar Jagannath, MD, Carlos E. Arce-Lara, MD, Jason Valent, MD, Ashley E Rosko, MD, Wael A. Harb, MD, Irwindeep Sandhu, MD, Nizar J Bahlis, MD, Donna Reece, Evangelos Terpos, MD, Jeffrey Supko, PhD, David Tamang, PhD, Simon S Jones, PhD, Catherine Wheeler, MD, Robert J Markelewicz, Jr., MD, Paul G. Richardson
Journal: Blood
Blood (2015) 126 (23): 4228.
https://doi.org/10.1182/blood.V126.23.4228.4228
Published: 2015
Journal Articles

Ricolinostat (ACY-1215), the First Selective HDAC6 Inhibitor, in Combination with Bortezomib and Dexamethasone in Patients with Relapsed or Relapsed-and-Refractory Multiple Myeloma: Phase 1b Results (ACY-100 Study)

Dan T. Vogl, MD, Noopur S. Raje, MD, Sundar Jagannath, MD, Paul G. Richardson, MD, Parameswaran Hari, MD MRCP, MS, Robert Z. Orlowski, PhD, MD, Jeffrey Supko, PhD, David Tamang, PhD, Simon S Jones, PhD, Catherine Wheeler, MD, Robert J Markelewicz, Jr., MD, Sagar Lonial, MD
Journal: Blood
Blood (2015) 126 (23): 1827.
https://doi.org/10.1182/blood.V126.23.1827.1827
Published: 2015
Journal Articles

Ricolinostat (ACY-1215), the First Selective HDAC6 Inhibitor, in Combonation with Lenalidomide and Dexamethasone in Patients with Relapsed and Relapsed-and-Refractory Multiple Myeloma: Phase 1b Results (ACE-MM-101 Study)

Andrew J. Yee, MD, William Bensinger, MD, Peter M. Voorhees, MD, Jesus G. Berdeja, MD, Paul G. Richardson, MD, Jeffrey Supko, PhD, David Tamang, PhD, Simon S Jones, PhD, Catherine Wheeler, MD, Robert J Markelewicz, Jr., MD, Noopur S. Raje, MD
Journal: Blood
Blood (2015) 126 (23): 3055.
https://doi.org/10.1182/blood.V126.23.3055.3055
Published: 2015